Well said. I was thinking the same about the CR. IMO it wasn't a mistake it had to happen and was just a matter of when. There was never going to be a good time, it was strategic and the best time that it could happen. All over and now not thinking about funding just getting through trials - hopefully with amazing results.
I'm glad they did it when they did instead of leaving it. It would be getting funded at 6c or 7c if they'd left it!
Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-56
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.8¢ |
Change
-0.008(2.11%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 34.8¢ | $405.9K | 1.152M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 252932 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 128093 | 9 |
View Market Depth
| Last trade - 12.19pm 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
